|
Volumn 65, Issue 3, 2015, Pages 311-312
|
Could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PREALBUMIN;
ARTIFICIAL HEART PACEMAKER;
CARDIOVASCULAR MAGNETIC RESONANCE;
CONTRAST ENHANCEMENT;
DIAGNOSTIC ACCURACY;
HEART AMYLOIDOSIS;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART MUSCLE CONDUCTION DISTURBANCE;
HEART MUSCLE INJURY;
HUMAN;
LETTER;
PACEMAKER IMPLANTATION;
RISK FACTOR;
TRANSCATHETER AORTIC VALVE IMPLANTATION;
AMYLOID NEUROPATHIES, FAMILIAL;
AORTA VALVE;
CARDIOMYOPATHIES;
HEART CATHETERIZATION;
HEART MUSCLE;
HEART VALVE REPLACEMENT;
PATHOLOGY;
PROCEDURES;
SURGERY;
AMYLOID NEUROPATHIES, FAMILIAL;
AORTIC VALVE;
CARDIAC CATHETERIZATION;
CARDIOMYOPATHIES;
HEART VALVE PROSTHESIS IMPLANTATION;
HUMANS;
MYOCARDIUM;
PACEMAKER, ARTIFICIAL;
|
EID: 84921325948
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2014.09.084 Document Type: Letter |
Times cited : (18)
|
References (5)
|